Alex Thurman
Director of Finance/CFO bij GLAUKOS CORPORATION
Vermogen: 5 M $ op 31-03-2024
Profiel
Alex Thurman is currently the Chief Financial Officer & Senior Vice President at Glaukos Corp.
and the Vice President-Finance at Allergan Ltd.
(Ireland).
He has an undergraduate and graduate degree from Brigham Young University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
GLAUKOS CORP
0.11% | 08-04-2024 | 52 532 ( 0.11% ) | 5 M $ | 31-03-2024 |
Actieve functies van Alex Thurman
| Bedrijven | Functie | Begin |
|---|---|---|
| GLAUKOS CORPORATION | Director of Finance/CFO | 01-04-2022 |
| ALLERGAN PLC | Director of Finance/CFO | 01-12-2016 |
Opleiding van Alex Thurman
| Brigham Young University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GLAUKOS CORPORATION | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
